Photographer: Simon Dawson/Bloomberg

AstraZeneca Seeking to Link Executive Pay to $45 Billion Target

  • Firm looking how to link long-term incentives to sales goal
  • Sunday Times said 20% of shareholders may reject CEO package

A board committee at AstraZeneca Plc is looking at ways to more clearly link executive compensation to a $45 billion revenue target amid reports of investor concern over the pay package of Chief Executive Officer Pascal Soriot.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.